Back to Search
Start Over
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
- Source :
-
Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2017 Oct; Vol. 15 (10), pp. 893-895. Date of Electronic Publication: 2017 Sep 21. - Publication Year :
- 2017
- Subjects :
- Anti-Bacterial Agents pharmacology
Carbapenem-Resistant Enterobacteriaceae drug effects
Carbapenem-Resistant Enterobacteriaceae isolation & purification
Enterobacteriaceae drug effects
Enterobacteriaceae isolation & purification
Enterobacteriaceae Infections microbiology
Humans
beta-Lactam Resistance drug effects
beta-Lactamase Inhibitors pharmacology
beta-Lactamases metabolism
beta-Lactams pharmacology
Anti-Bacterial Agents administration & dosage
Enterobacteriaceae Infections drug therapy
beta-Lactamase Inhibitors administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8336
- Volume :
- 15
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Expert review of anti-infective therapy
- Publication Type :
- Editorial & Opinion
- Accession number :
- 28914107
- Full Text :
- https://doi.org/10.1080/14787210.2017.1380519